The Deane Institute for Integrated Research on Atrial Fibrillation and Stroke

Massachusetts General Hospital has created our nation's first multi-specialty institute dedicated to the prevention and treatment of atrial fibrillation and one of its most devastating complications – stroke.

The Deane Institute for Integrated Research on Atrial Fibrillation and Stroke at MGH was founded through the generosity of Carol and Disque Deane. It was established as a one-of-a-kind research and education institute whose primary goals are to:

• Pinpoint the genetic roots of Atrial Fibrillation (AF) and embolic stroke in AF.
• Determine the genetic basis for stroke in patients with AF who are predisposed to develop this complication.
• Identify patients who are at high risk for intracerebral hemorrhage, a feared complication of anticoagulation therapy used to reduce stroke risk in patients with AF.
• Develop new devices for treating AF without drugs and for preventing stroke in patients with AF.
• Educate primary care physicians and other caregivers in the diagnosis and treatment of AF.
• Train a new generation of physicians in neuro-cardiology.

For more information, please see the following pages:

• About the Institute - More information about the Deane Institute and its mission.
• Current Projects - The current neurology research projects at the Deane Institute.
• Leadership - The Deane Insititute's leadership.

© 2009 Massachusetts General Hospital | 15 Parkman Street Boston, MA. 02114 | (617) 726-8459
Home | Contact Us | Donate | Sitemap | Disclaimer | Email the Webmaster